IN8BIO INC's ticker is and the CUSIP is 45674E109. A total of 18 filers reported holding IN8BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $77,032 | -79.8% | 91,000 | -71.9% | 0.01% | -75.0% |
| Q1 2024 | $381,705 | -18.9% | 323,479 | -5.2% | 0.03% | -30.4% |
| Q4 2023 | $470,868 | -11.5% | 341,209 | -33.3% | 0.05% | -31.3% |
| Q3 2023 | $532,048 | -24.5% | 511,584 | +11.7% | 0.07% | -21.2% |
| Q2 2023 | $705,129 | +60.5% | 457,876 | +35.5% | 0.08% | +49.1% |
| Q1 2023 | $439,424 | -43.7% | 338,019 | 0.0% | 0.06% | -62.5% |
| Q4 2022 | $780,824 | +2.9% | 338,019 | -10.0% | 0.15% | -30.0% |
| Q3 2022 | $759,000 | -33.6% | 375,570 | -25.7% | 0.22% | -41.5% |
| Q2 2022 | $1,143,000 | +30.6% | 505,635 | +95.2% | 0.37% | +34.9% |
| Q1 2022 | $875,000 | +96.2% | 259,003 | +154.5% | 0.28% | +99.3% |
| Q4 2021 | $446,000 | -19.6% | 101,779 | +26.1% | 0.14% | -39.5% |
| Q3 2021 | $555,000 | – | 80,727 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRECEPT MANAGEMENT LLC | 50,000 | $101,000 | 0.72% |
| Voss Capital, LP | 375,570 | $759,000 | 0.22% |
| Stonegate Investment Group, LLC | 232,310 | $469,000 | 0.02% |
| Sigma Planning Corp | 98,750 | $199,000 | 0.01% |
| Warberg Asset Management LLC | 15,000 | $30,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 74,000 | $149,000 | 0.00% |
| United Asset Strategies, Inc. | 14,000 | $28,000 | 0.00% |
| Ensign Peak Advisors, Inc | 70,028 | $141,000 | 0.00% |
| HighTower Advisors, LLC | 14,164 | $28,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,821 | $4,000 | 0.00% |